Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Courtney Nicole Miller-Chism"'
Autor:
Courtney Nicole Miller-Chism, Harinder S. Juneja, Curtis Lachowiez, Hilary Y. Ma, Martha P. Mims, Wei Qiao, Onyebuchi Ononogbu, Mark M. Udden, Effrosyni Apostolidou
Publikováno v:
Clin Lymphoma Myeloma Leuk
Despite therapeutic advances and improvement in outcomes of patients with acute lymphoblastic leukemia, as reported by specialized centers, healthcare disparities exist. This is a retrospective cohort analysis of the clinical outcomes of 146 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9184d57e3366a83ef7248790274bf793
https://doi.org/10.1016/j.clml.2021.06.022
https://doi.org/10.1016/j.clml.2021.06.022
Autor:
Kevin Tang, Heidi M Krause, Nikhil Patel, Grace Hwang, Jason Lu, Martha P. Mims, Mark M. Udden, Courtney Nicole Miller-Chism, Gustavo Rivero, Purnima Sravanti Teegavarapu
Publikováno v:
Blood. 140:8101-8102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cbb1574e1bd55cd43910036ab433d62
https://doi.org/10.1182/blood-2022-168224
https://doi.org/10.1182/blood-2022-168224
Publikováno v:
Cancer Research. 80:P2-10
BACKGROUND African Americans comprise 12% of the total United States population. Lifetime probability of developing cancer in African Americans is 37.55%. Lifetime probability of developing breast cancer in African Americans is 11.1%. African America
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::693e4ca1c8d7546a9a1eb7ff1bd626a7
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-11
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-11
Autor:
Aparna Chakravarti Jotwani, Anita L. Sabichi, Vlad C. Sandulache, Daniel Y. Wang, David J. Hernandez, Nan Chen, Quillan Huang, Jan Ole Kemnade, Wendy W Du, Courtney Nicole Miller-Chism, Marcus A Florez, Albert C. Chen
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of both lung cancer and head and neck squamous cell carcinoma demonstrating clear benefit over traditional chemotherapy alone in the metastatic setting. While the overwhelming majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28a97dd5fe4414d114551155a3a2b952
https://doi.org/10.1101/2021.11.26.21266821
https://doi.org/10.1101/2021.11.26.21266821
Publikováno v:
Ann Intern Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a15fd3f411b1a533cc5f2f0141d3f54e
https://pubmed.ncbi.nlm.nih.gov/34126033
https://pubmed.ncbi.nlm.nih.gov/34126033
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(9)
BACKGROUND Daratumumab is an anti-CD38 monoclonal antibody that is used more frequently in patients with Multiple Myeloma (MM). Multiple studies have demonstrated the efficacy and safety of daratumumab for relapsed/refractory MM and primary treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1517d5f3d86aa20ff57be5957e607df4
https://pubmed.ncbi.nlm.nih.gov/32409106
https://pubmed.ncbi.nlm.nih.gov/32409106
Autor:
Deepa Dongarwar, Sara Taveras Alam, Quillan Huang, Courtney Nicole Miller-Chism, Elyse Lopez, Hamisu M. Salihu, Martha P. Mims, Gustavo A. Rivero, Sarvari Venkata Yellapragada
Publikováno v:
Blood. 138:4135-4135
Background: Acute Myeloid Leukemia (AML) outcomes are dependent on leukemia-specific factors, such as cytogenetics and patient-specific factors, such as age and performance status. Racial and socioeconomic disparities have become apparent with self-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dcb668a84913ce55e5467985904744b
https://doi.org/10.1182/blood-2021-153029
https://doi.org/10.1182/blood-2021-153029
Autor:
Courtney Nicole Miller-Chism, Lee B Lu, Mahmoud R. Gaballa, Kallie N Kram, Scott N Berger, Albert Jang, David Dunaway
Publikováno v:
Case Reports in Medicine, Vol 2020 (2020)
Case Reports in Medicine
Case Reports in Medicine
Spinal cord compression (SCC) is a rare initial presentation and complication of acute lymphoblastic leukemia (ALL) with nearly all reported cases occurring in the pediatric population. We report a 38-year-old previously healthy man who presented wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd62ff2709cc3a5e0c75a88dbe859d22
https://doaj.org/article/f83d996704394b6a9fafa4f45d45d6fb
https://doaj.org/article/f83d996704394b6a9fafa4f45d45d6fb
Autor:
Margaret Griffin Crawford, Claire M. Mach, Kyler M. Godwin, Courtney Nicole Miller-Chism, Jessica Zhang, LaToya Woods, Aparna Chakravarti Jotwani, Daniel R. Murphy
Publikováno v:
Journal of Clinical Oncology. 39:e18665-e18665
e18665 Background: Clinic cycle time is a performance metric and prolonged wait times may impact patient satisfaction and/or treatment outcomes. In primary care clinics, studies show prolonged cycle times detract from patient satisfaction. Fewer stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aa008cc9248e8557b06249c022078d0
https://doi.org/10.1200/jco.2021.39.15_suppl.e18665
https://doi.org/10.1200/jco.2021.39.15_suppl.e18665
Publikováno v:
Blood. 134:2160-2160
Background: The prevalence of venous thromboembolism (VTE) varies by race/ethnicity, with African-Americans displaying a significantly higher rate compared to Caucasians, and with Asian/Pacific Islanders and Hispanics experiencing the lowest rates. G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d5cd0f65e205b3c2ee3c595b55d1417
https://doi.org/10.1182/blood-2019-129142
https://doi.org/10.1182/blood-2019-129142